Aptahem

Aptahem AB (publ) is a clinical stage biotechnology company that develops RNA-based pharmaceuticals, also referred to as aptamers, for the treatment of acute, life-threatening conditions in which a combination of coagulation, inflammation and tissue damage are involved. Aptahem’s goal is to address the global medical need of treatments for sepsis and other acute inflammatory conditions.

ADDRESS
Aptahem AB
Medeon Science Park
SE-205 12 Malmö